Manar Zraikat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Manar Zraikat has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Ahmad Riyad Alsayed
Applied Science Private University, Amman, Jordan, Jordan
3 shared publications - Heba A. Khader
Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa 13133, Jordan
3 shared publications - Luai Hasoun
Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman 11931, Jordan
3 shared publications - Malek Zihlif
Department of Pharmacology, Faculty of Medicine, The University of Jordan, Amman 11942, Jordan
3 shared publications - Eman Abdullah Alsuof
Department of Pharmacology, School of Medicine, The University of Jordan, Amman 11942, Jordan
2 shared publications - Mahmoud Abu-Samak
Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan
2 shared publications
Latest Publications
- Open Access
- 17 September 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (9) , 937
Beyond Culture: Real-Time PCR Performance in Detecting Causative Pathogens and Key Antibiotic Resistance Genes in Hospital-Acquired Pneumonia
Introduction: The rise in hospital-acquired pneumonia (HAP) due to antibiotic-resistant bacteria is increasing morbidity, mortality, and inappropriate empirical antibiotic use. This prospective research aimed to evaluate the performance of a real-time polymerase chain reaction (PCR) assay for detecting causative microorganisms and antibiotic-resistance genes from respiratory specimens compared to traditional methods. Additionally, we aimed to determine the molecular epidemiology of antibiotic resistance genes among HAP patients at The University of Jordan hospital. Methods: Lower respiratory tract samples were collected from HAP patients, including those with ventilator-associated pneumonia (VAP), between May 2024 and October 2024. Clinical data from the medical files were used to collect and analyze demographic and clinical information, including clinical outcomes. Real-time PCR was run to detect causative microbes and antibiotic resistance genes. Results: Among 83 HAP patients (median age 63, 61.45% male), 48.15% died. Culture identified Klebsiella (25.53%), Acinetobacter (22.34%), and Candida (24.47%) as the most common pathogens, while qPCR showed higher detection rates, including for A. baumannii (62.20%, p = 0.02) and K. pneumoniae (45.12%, p < 0.001). Carbapenem resistance was high; A. baumannii showed 100% resistance to most antibiotics except colistin (92.31%). The resistance genes ndm (60%) and oxa-48 (58.46%) were frequently detected and significantly associated with phenotypic resistance (p < 0.001). The qPCR identified resistance genes in all carbapenem-resistant cases. No gene significantly predicted mortality. Conclusions: Real-time PCR diagnostic technique combined with epidemiology of antibiotic resistance genes data may be a rapid and effective tool to improve HAP management. Large, multicenter studies are needed in the future to validate the performance of real-time PCR in HAP diagnosis, and appropriate management is also required.
- 17 September 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (9) , 937
Open AccessBeyond Culture: Real-Time PCR Performance in Detecting Causative Pathogens and Key Antibiotic Resistance Genes in Hospital-Acquired Pneumonia
Introduction: The rise in hospital-acquired pneumonia (HAP) due to antibiotic-resistant bacteria is increasing morbidity, mortality, and inappropriate empirical antibiotic use. This prospective research aimed to evaluate the performance of a real-time polymerase chain reaction (PCR) assay for detecting causative microorganisms and antibiotic-resistance genes from respiratory specimens compared to traditional methods. Additionally, we aimed to determine the molecular epidemiology of antibiotic resistance genes among HAP patients at The University of Jordan hospital. Methods: Lower respiratory tract samples were collected from HAP patients, including those with ventilator-associated pneumonia (VAP), between May 2024 and October 2024. Clinical data from the medical files were used to collect and analyze demographic and clinical information, including clinical outcomes. Real-time PCR was run to detect causative microbes and antibiotic resistance genes. Results: Among 83 HAP patients (median age 63, 61.45% male), 48.15% died. Culture identified Klebsiella (25.53%), Acinetobacter (22.34%), and Candida (24.47%) as the most common pathogens, while qPCR showed higher detection rates, including for A. baumannii (62.20%, p = 0.02) and K. pneumoniae (45.12%, p < 0.001). Carbapenem resistance was high; A. baumannii showed 100% resistance to most antibiotics except colistin (92.31%). The resistance genes ndm (60%) and oxa-48 (58.46%) were frequently detected and significantly associated with phenotypic resistance (p < 0.001). The qPCR identified resistance genes in all carbapenem-resistant cases. No gene significantly predicted mortality. Conclusions: Real-time PCR diagnostic technique combined with epidemiology of antibiotic resistance genes data may be a rapid and effective tool to improve HAP management. Large, multicenter studies are needed in the future to validate the performance of real-time PCR in HAP diagnosis, and appropriate management is also required.
- Open Access
- 13 May 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (5) , 502
Molecular Detection of Antibiotic Resistance Genes Using Respiratory Sample from Pneumonia Patients
Introduction/Objectives: Antibiotic resistance makes the treatment of pneumonia challenging. Effective management depends on accurate diagnostic techniques to identify resistance genes and customize drugs. This study primarily aimed to identify antibiotic resistance genes in respiratory samples from patients with pneumonia using polymerase chain reaction (PCR) to determine the prevalence of specific resistance genes and analyze clinical factors contributing to antibiotic resistance, as well as to provide actionable insights into resistance patterns in Jordan and support efforts to improve pneumonia management. Methods: This retrospective observational study included 114 patients who were diagnosed with pneumonia. Clinical data, including prior antibiotic exposure and treatment history, were collected. PCR diagnostics were used to detect resistance genes in respiratory samples. In this study, we evaluated 14 antibiotic resistance genes in pneumonia pathogens, highlighting their diverse resistance mechanisms. Results: Mec A was the most frequently detected gene, appearing in 87 samples (77.3%). Additionally, Tem in 80 samples (70.2%), Oxa-48-like in 15 samples (13.2%), and Ctx-M-1 in 38 samples (33.3%) were among the most commonly detected genes. In contrast, Oxa-40-like (7.0%), Vim (8.8%), and Imp (4.4%) genes exhibited a lower prevalence. The Oxa-51-like gene showed the only significant association with ertapenem resistance (p-value = 0.046). Further analysis revealed statistically significant associations between Mec A and methicillin resistance (p < 0.001), underscoring its critical role. However, other genes, such as Oxa-40-like and Oxa-48-like, showed no significant correlation with the antibiotic resistance patterns of imipenem and meropenem (p > 0.05). Conclusions: This study demonstrates the utility of PCR-based diagnostics for detecting resistance genes and highlights the critical clinical factors associated with antibiotic resistance in patients with pneumonia. These findings underscore the importance of integrating molecular diagnostics into routine care to improve treatment outcomes and combat the growing threat of antibiotic resistance in Jordan. This highlights PCR’s value in guiding effective treatment strategies and addressing multidrug-resistant pneumonia.
- 13 May 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (5) , 502
Open AccessMolecular Detection of Antibiotic Resistance Genes Using Respiratory Sample from Pneumonia Patients
Introduction/Objectives: Antibiotic resistance makes the treatment of pneumonia challenging. Effective management depends on accurate diagnostic techniques to identify resistance genes and customize drugs. This study primarily aimed to identify antibiotic resistance genes in respiratory samples from patients with pneumonia using polymerase chain reaction (PCR) to determine the prevalence of specific resistance genes and analyze clinical factors contributing to antibiotic resistance, as well as to provide actionable insights into resistance patterns in Jordan and support efforts to improve pneumonia management. Methods: This retrospective observational study included 114 patients who were diagnosed with pneumonia. Clinical data, including prior antibiotic exposure and treatment history, were collected. PCR diagnostics were used to detect resistance genes in respiratory samples. In this study, we evaluated 14 antibiotic resistance genes in pneumonia pathogens, highlighting their diverse resistance mechanisms. Results: Mec A was the most frequently detected gene, appearing in 87 samples (77.3%). Additionally, Tem in 80 samples (70.2%), Oxa-48-like in 15 samples (13.2%), and Ctx-M-1 in 38 samples (33.3%) were among the most commonly detected genes. In contrast, Oxa-40-like (7.0%), Vim (8.8%), and Imp (4.4%) genes exhibited a lower prevalence. The Oxa-51-like gene showed the only significant association with ertapenem resistance (p-value = 0.046). Further analysis revealed statistically significant associations between Mec A and methicillin resistance (p < 0.001), underscoring its critical role. However, other genes, such as Oxa-40-like and Oxa-48-like, showed no significant correlation with the antibiotic resistance patterns of imipenem and meropenem (p > 0.05). Conclusions: This study demonstrates the utility of PCR-based diagnostics for detecting resistance genes and highlights the critical clinical factors associated with antibiotic resistance in patients with pneumonia. These findings underscore the importance of integrating molecular diagnostics into routine care to improve treatment outcomes and combat the growing threat of antibiotic resistance in Jordan. This highlights PCR’s value in guiding effective treatment strategies and addressing multidrug-resistant pneumonia.
- Open Access
- 31 March 2025
- Published by MDPI AG in Preprints.org
Molecular Detection of Antibiotic Resistance Genes using Respiratory Sample from Pneumonia Patients
Introduction/Objectives: Antibiotic resistance makes treatment for pneumonia challenging. Effective management depends on accurate diagnosis techniques to find resistance genes and customize drugs. This study primarily aimed to identify antibiotic resistance genes in respiratory samples from pneumonia patients using PCR to determine the prevalence of specific resistance genes and analyze clinical factors contributing to antibiotic resistance to provide actionable insights into resistance patterns in Jordan and support efforts to improve pneumonia management. Methods: This retrospective observational study was conducted involving 114 patients diagnosed with pneumonia. Clinical data, including prior antibiotic exposure and treatment history, were collected. PCR diagnostics were utilized to detect resistance genes in respiratory samples. This study evaluated 14 antibiotic resistance genes in pneumonia pathogens, highlighting diverse resistance mechanisms. Results: The Mec A gene was the most frequently detected, appearing in 87 samples (77.3%). Additionally, Tem in 80 samples (70.2%), Oxa-48-like in 15 samples (13.2%), and Ctx-M-1 38 samples (33.3%) were among the most common detected genes. In contrast, genes such as Oxa-40-like (7.0%), Vim (8.8%), and Imp (4.4%) exhibited lower prevalence. The Oxa-51-like gene showed the only significant association with Ertapenem resistance (p-value=0.046). Further analysis revealed statistically significant associations between the Mec A gene and methicillin resistance (p0.05). Conclusions: This research demonstrates the utility of PCR-based diagnostics in detecting resistance genes and highlights critical clinical factors associated with antibiotic resistance in pneumonia patients. The findings underscore the importance of integrating molecular diagnostics into routine care to improve treatment outcomes and combat the growing threat of antibiotic resistance in Jordan. This highlights PCR’s value in guiding effective treatment strategies and addressing multidrug-resistant pneumonia.
- 31 March 2025
- Published by MDPI AG in Preprints.org
Open AccessMolecular Detection of Antibiotic Resistance Genes using Respiratory Sample from Pneumonia Patients
Introduction/Objectives: Antibiotic resistance makes treatment for pneumonia challenging. Effective management depends on accurate diagnosis techniques to find resistance genes and customize drugs. This study primarily aimed to identify antibiotic resistance genes in respiratory samples from pneumonia patients using PCR to determine the prevalence of specific resistance genes and analyze clinical factors contributing to antibiotic resistance to provide actionable insights into resistance patterns in Jordan and support efforts to improve pneumonia management. Methods: This retrospective observational study was conducted involving 114 patients diagnosed with pneumonia. Clinical data, including prior antibiotic exposure and treatment history, were collected. PCR diagnostics were utilized to detect resistance genes in respiratory samples. This study evaluated 14 antibiotic resistance genes in pneumonia pathogens, highlighting diverse resistance mechanisms. Results: The Mec A gene was the most frequently detected, appearing in 87 samples (77.3%). Additionally, Tem in 80 samples (70.2%), Oxa-48-like in 15 samples (13.2%), and Ctx-M-1 38 samples (33.3%) were among the most common detected genes. In contrast, genes such as Oxa-40-like (7.0%), Vim (8.8%), and Imp (4.4%) exhibited lower prevalence. The Oxa-51-like gene showed the only significant association with Ertapenem resistance (p-value=0.046). Further analysis revealed statistically significant associations between the Mec A gene and methicillin resistance (p0.05). Conclusions: This research demonstrates the utility of PCR-based diagnostics in detecting resistance genes and highlights critical clinical factors associated with antibiotic resistance in pneumonia patients. The findings underscore the importance of integrating molecular diagnostics into routine care to improve treatment outcomes and combat the growing threat of antibiotic resistance in Jordan. This highlights PCR’s value in guiding effective treatment strategies and addressing multidrug-resistant pneumonia.
- 1 July 2020
- Published by SAGE Publications in ASSAY and Drug Development Technologies
- Vol. 18 (5) , 239-242
Comparison Between Different 3D Spheroid Tumor Invasion Models
This study aims to make a comparison between different forms of three-dimensional (3D) spheroid U87 tumor cell models that contain fibroblast cells as part of the tumor microenvironment. This purpose is to select the best representative tumor model to be used for further studies to investigate the effects of the anti-invasive pharmacological agents. For this purpose, different options to prepare the 3D spherical invasion model were tested based on the ability of the spheroids to invade in collagen microenvironment. There was a significant positive effect of the fibroblasts on the invasion of the U87 cells in the 3D invasion model compared with the control model that contains U87 cells alone. This result gives proof of the positive effect of the fibroblasts on invasion of tumor cells. Furthermore, these results add more proofs on the importance of adding cells of the tumor microenvironments to the tumor models to make the models more representative to the real in vivo tumor situation.
- 1 July 2020
- Published by SAGE Publications in ASSAY and Drug Development Technologies
- Vol. 18 (5) , 239-242
Comparison Between Different 3D Spheroid Tumor Invasion Models
This study aims to make a comparison between different forms of three-dimensional (3D) spheroid U87 tumor cell models that contain fibroblast cells as part of the tumor microenvironment. This purpose is to select the best representative tumor model to be used for further studies to investigate the effects of the anti-invasive pharmacological agents. For this purpose, different options to prepare the 3D spherical invasion model were tested based on the ability of the spheroids to invade in collagen microenvironment. There was a significant positive effect of the fibroblasts on the invasion of the U87 cells in the 3D invasion model compared with the control model that contains U87 cells alone. This result gives proof of the positive effect of the fibroblasts on invasion of tumor cells. Furthermore, these results add more proofs on the importance of adding cells of the tumor microenvironments to the tumor models to make the models more representative to the real in vivo tumor situation.
- Open Access
- 1 January 2017
- Published by Scitechnol Biosoft Pvt. Ltd. in Archives in Cancer Research
- Vol. 5 (2)
Tumour Dissemination and Assays Involved
Tumour dissemination is a major reason for failure of therapy for many tumour types. Metastasis and angiogenesis result from the interaction between the tumour cells in the tumour microenvironment. The detailed picture of tumour and the tumour microenvironment interaction however is not fully understood due to a lack of representative models. This review shows a brief summary of the assays and models used to describe the tumour dissemination process.
- 1 January 2017
- Published by Scitechnol Biosoft Pvt. Ltd. in Archives in Cancer Research
- Vol. 5 (2)
Open AccessTumour Dissemination and Assays Involved
Tumour dissemination is a major reason for failure of therapy for many tumour types. Metastasis and angiogenesis result from the interaction between the tumour cells in the tumour microenvironment. The detailed picture of tumour and the tumour microenvironment interaction however is not fully understood due to a lack of representative models. This review shows a brief summary of the assays and models used to describe the tumour dissemination process.